TSX News -
Novo Resources Corp. Announces Resignation of Ross Hamilton as Director
VANCOUVER, British Columbia, June 04, 2024 (GLOBE NEWSWIRE) — Novo Resources Corp. (Novo or the Company) (ASX: NVO) (TSX: NVO) […]
Toll Brothers Announces New Luxury Home Community Coming Soon to Centennial, Colorado
CENTENNIAL, Colo., June 04, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today […]
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health […]
Toll Brothers Announces New Luxury Home Community Coming Soon to Tigard, Oregon
TIGARD, Ore., June 04, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced […]
Sezzle Set to Join Russell 3000® Index
Minneapolis, MN, June 04, 2024 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, […]
TSX News -
Trisura Group Announces Results of Annual Meeting of Shareholders
TORONTO, June 04, 2024 (GLOBE NEWSWIRE) — Trisura Group Ltd. (“Trisura Group” or the “Company”) (TSX: TSU) today announced the […]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
ZUG, Switzerland, June 04, 2024 (GLOBE NEWSWIRE) — The attached notifications relate to the annual equity incentive awards granted to […]
Total Voting Rights, PDMR Notification and Stock Option Awards
Reykjavik, June 04, 2024 (GLOBE NEWSWIRE) — “Amaroq” or the “Company” Total Voting Rights, PDMR Notification and Stock Option Awards […]
TSX News -
UPDATE – Significant Results From Diamond Drilling at Belltopper, Victoria
HIGHLIGHTS A six-hole, 2,529 m, diamond drill program has been completed at the Belltopper Gold Project in Victoria. Significant intercepts […]
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
Encouraging clinical activity with observed deepening of responses in 35 evaluable first line head and neck patients treated with HB-200 […]
